Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
RXDgPGzc9B8rjPhz
Listen
Français